Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On population and individual bioequivalence

R Schall1, H G Luus

  • 1Department of Pharmacology, University of the Orange Free State, Bloemfontein, R.S.A.

Statistics in Medicine
|June 30, 1993
PubMed
Summary

This study introduces a unified strategy for assessing drug bioequivalence, improving upon traditional methods by considering bioavailability variability. The new approach enhances both population and individual bioequivalence assessments for more robust drug comparisons.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between core stability and athletic performance in female university athletes.

South African journal of sports medicine·2023
Same author

Epidemiology of injuries among U18, U19, U21 and senior elite netball players.

South African journal of sports medicine·2023
Same author

Physical and physiological profile of U18, U19, U21 and senior elite netball players.

South African journal of sports medicine·2023
Same author

Sample size determination in bioequivalence studies using statistical assurance.

British journal of clinical pharmacology·2019
Same author

Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis-A South African perspective.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same author

Cost Effectiveness of G:CSF in Chemotherapy and Transplant-related Neutropenia.

Hematology (Amsterdam, Netherlands)·2016

Area of Science:

  • Pharmacokinetics
  • Biopharmaceutics
  • Statistical Modeling

Background:

  • Traditional bioequivalence assessment focuses on average bioavailability between drug formulations.
  • Existing methods may not adequately capture individual variability, as highlighted by Anderson and Hauck's work on individual bioequivalence.

Purpose of the Study:

  • To propose a unified strategy for assessing bioequivalence.
  • To develop new approaches for evaluating both population and individual bioequivalence.
  • To address the limitations of current methods by incorporating bioavailability variability.

Main Methods:

  • A unified strategy comparing reference formulation to itself as a basis for test-reference comparison.
  • Development of new statistical criteria for population and individual bioequivalence.

Related Experiment Videos

  • Utilizing bootstrap confidence intervals for statistical evaluation.

    • Main Results:

    • The proposed unified strategy encompasses both population and individual bioequivalence.
    • New methods consider bioavailability variability alongside means, overcoming a key weakness of current approaches.
    • Conventional average bioequivalence and Anderson-Hauck's individual bioequivalence emerge as special cases.

    Conclusions:

    • The unified strategy offers a more comprehensive assessment of drug bioequivalence.
    • The new methods provide a statistically sound framework for evaluating drug formulation differences.
    • This approach enhances the reliability of bioequivalence studies by accounting for variability.